Company

Oncostellae SL

Santiago de Compostela-based clinical-stage biopharmaceutical company developing small-molecule drugs.

About

Oncostellae SL is a clinical-stage biopharmaceutical company developing small-molecule drugs for oncology and inflammatory disease. Its pipeline includes OST-122, targeting inflammatory bowel disease, and OST-499, being developed for uterine fibroids and other gynecological conditions. Founded in 2013 and based in Santiago de Compostela, Spain, it was founded by Julio Castro. In March 2024 it raised EUR 500,000 in Series A funding from the Center for Technological & Industrial Development and Noso Capital.

5Funding rounds

6Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in